Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment offers patient access and clinical trial technology solutions to customers specializing in complex randomization and optimization of the trial drug supply process. The company caters to pharmaceutical, biotechnology, and medical device customers.